Petlife Pharmaceuticals, Inc.
PTLF
$0.0001
$0.000.00%
| 02/28/2018 | 11/30/2017 | 08/31/2017 | 05/31/2017 | 02/28/2017 | |
|---|---|---|---|---|---|
| Net Income | 84.48% | 79.69% | -530.78% | -6,286.02% | -8,731.35% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 97.60% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.85% | -75.97% | 2,930.39% | 24,251.66% | 23,530.86% |
| Change in Net Operating Assets | -84.18% | -107.66% | -83.79% | 791.46% | 1,407.05% |
| Cash from Operations | 46.68% | 23.33% | -110.08% | -9,986.21% | -8,225.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -31.22% | -8.78% | 165.95% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.21% | -22.48% | 143.20% | 9,993.10% | 8,377.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,750.00% | -12.76% | 4,316.67% | -- | 500.00% |
